Independent prognostic effect of co-morbidity in lymphoma patients: Results of the population-based Eindhoven Cancer Registry

European Journal of Cancer

Volumn 41, Issue 7, 2005, Pages 1051-1057

  Van Spronsen, D J ^a   Janssen Heijnen, M L G ^b   Lemmens, V E P P ^b   Peters, W G ^c   Coebergh, J W W ^b,d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Co morbidity; Elderly; Lymphoma; Survival; Treatment

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SURVIVAL TIME;

EID: 18044367910     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.01.010     Document Type: Article

References (33)

1. J.R. Cerhan, R.B. Wallace, and A.R. Folsom Medical history risk factors for non-Hodgkin's lymphoma in older women J Natl Cancer Inst 89 1997 314 318
2. E. Maartense, H.C. Kluin-Nelemans, and E.M. Noordijk Non-Hodgkin's lymphoma in the elderly. A review with emphasis on elderly patients, geriatric assessment, and future perspectives Ann Hematol 82 2003 661 670
3. D.J. van Spronsen, I.M. Dijkema, and L.W. Vrints Improved survival of Hodgkin's patients in south-east Netherlands since 1972 Eur J Cancer 33 1997 436 441
4. A.D. Krol, S. le Cessie, and S. Snijder Non-Hodgkin's lymphoma in the Netherlands: results from a population-based registry Leuk Lymphoma 44 2003 451 458
5. P. Roy, G. Vaughan Hudson, and B. Vaughan Hudson Long-term survival in Hodgkin's disease patients. A comparison of relative survival in patients in trials and those recorded in population-based cancer registries Eur J Cancer 36 2000 384 389
6. D.J. van Spronsen, M.L. Janssen-Heijnen, and W.P. Breed Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996 Ann Hematol 78 1999 315 319
7. H.L. Haak, P.M. Kluin, and C.J. Meyer Population-based registration of non-Hodgkin lymphoma in the region covered by the Comprehensive Cancer Centre West. The registry of diagnosis and therapy Neth J Med 29 1986 105 110
8. J.M. de Rijke, L.J. Schouten, and H.C. Schouten Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands Ann Oncol 7 1996 677 685
9. J.M. Vose, J.O. Armitage, and D.D. Weisenburger The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma J Clin Oncol 6 1988 1838 1844
10. P. Solal-Celigny, C. Chastang, and A. Herrera Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma Am J Med 83 1987 1075 1079
11. U. Tirelli, V. Zagonel, and D. Serraino Non-Hodgkin's lymphomas in 137 patients aged 70 years or older: a retrospective European Organization for Research and Treatment of Cancer Lymphoma Group Study J Clin Oncol 6 1988 1708 1713
12. E. Maartense, J. Hermans, and J.C. Kluin-Nelemans Elderly patients with non-Hodgkin's lymphoma: population-based results in The Netherlands Ann Oncol 9 1998 1219 1227
13. M.E. Charlson, P. Pompei, and K.L. Ales A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
14. L.J. Schouten, P. Hoppener, and P.A. van den Brandt Completeness of cancer registration in Limburg, The Netherlands Int J Epidemiol 22 1993 369 376
15. S.M. Kieszak, W.D. Flanders, and A.S. Kosinski A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data J Clin Epidemiol 52 1999 137 142
16. C.J. Newschaffer, T.L. Bush, and L.T. Penberthy Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data J Clin Epidemiol 50 1997 725 733
17. P.P. Carbone, H.S. Kaplan, and K. Musshoff Report of the Committee on Hodgkin's Disease Staging Classification Cancer Res 31 1971 1860 1861
18. N.L. Harris, E.S. Jaffe, and J. Diebold World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997 J Clin Oncol 17 1999 3835 3849
19. T. Hakulinen, and K.H. Abeywickrama A computer program package for relative survival analysis Comput Programs Biomed 19 1985 197 207
20. R. Sonnen, W.P. Schmidt, and R. Kuse Treatment results of aggressive B non-Hodgkin's lymphoma in advanced age considering comorbidity Br J Haematol 119 2002 634 639
21. R. Yancik, M.N. Wesley, and L.A. Ries Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study Cancer 82 1998 2123 2134
22. P. Thomas, M. Piraux, and L.F. Jacques Clinical patterns and trends of outcome of elderly patients with bronchogenic carcinoma Eur J Cardiothorac Surg 13 1998 266 274
23. J.F. Piccirillo Importance of comorbidity in head and neck cancer Laryngoscope 110 2000 593 602
24. M. Extermann Measuring comorbidity in older cancer patients Eur J Cancer 36 2000 453 471
25. W.A. Satariano, and D.R. Ragland The effect of comorbidity on 3-year survival of women with primary breast cancer Ann Intern Med 120 1994 104 110
26. P.C. Albertsen, D.G. Fryback, and B.E. Storer The impact of co-morbidity on life expectancy among men with localized prostate cancer J Urol 156 1996 127 132
27. P.N. Post, B.E. Hansen, and P.J. Kil The independent prognostic value of comorbidity among men aged <75 years with localized prostate cancer: a population-based study BJU Int 87 2001 821 826
28. M.L. Janssen-Heijnen, S. Smulders, and V.E. Lemmens Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer Thorax 59 2004 602 607
29. R.I. Fisher, E.R. Gaynor, and S. Dahlberg Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma N Engl J Med 328 1993 1002 1006
30. Y. Bastion, J.Y. Blay, and M. Divine Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival - a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years J Clin Oncol 15 1997 2945 2953
31. K.M. Ardeshna, P. Smith, and A. Norton Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial Lancet 362 2003 516 522
32. M. Extermann, J. Overcash, and G.H. Lyman Comorbidity and functional status are independent in older cancer patients J Clin Oncol 16 1998 1582 1587
33. S. Firat, R.W. Byhardt, and E. Gore Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 54 2002 357 364